-
Case Studies
Hyper-Specificity in Product Positioning – ForeSights
"ForeSights Case Study: Hyper-Specificity in Product Positioning" analyzes the emerging trend where consumers are seeking highly-personalized and specific product claims. It can be described as a tool to build brand loyalty and present the authenticity and history of products. In the ubiquitous mass-market, where many products became standardized, a rising number of consumers are looking for more authentic goods with hyper-specific claims. To make purchasing decisions easier and justify one’s choice, buyers want to know more about the goods they...
-
Product Insights
NewLikelihood of Approval Analysis for Female Hypoactive Sexual Desire Disorder
Overview How likely is it that the drugs in Female Hypoactive Sexual Desire Disorder will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Female Hypoactive Sexual Desire Disorder Overview Hypoactive sexual desire...
-
Product Insights
Blackstone Group – Airoli Hyper-Scale Data Center – Maharashtra
Equip yourself with the essential tools needed to make informed and profitable decisions with our Blackstone Group – Airoli Hyper-Scale Data Center – Maharashtra report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Acquire a thorough understanding of the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Emapalumab in Systemic Lupus Erythematosus
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Emapalumab in Systemic Lupus Erythematosus report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Emapalumab in Systemic Lupus Erythematosus Drug Details: Emapalumab (Gamifant) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Emapalumab in Arthritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Emapalumab in Arthritis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Emapalumab in Arthritis Drug Details: Emapalumab (Gamifant) is a monoclonal antibody, acts...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Emapalumab in Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Emapalumab in Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Emapalumab in Systemic-Onset Juvenile Idiopathic Arthritis (Still...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Anakinra in Intracerebral Hemorrhage
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Anakinra in Intracerebral Hemorrhage report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anakinra in Intracerebral Hemorrhage Drug Details: Anakinra (Kineret) is an immunosuppressant...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Anakinra in Cytokine Release Syndrome (Cytokine Storm)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Anakinra in Cytokine Release Syndrome (Cytokine Storm) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anakinra in Cytokine Release Syndrome (Cytokine Storm) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Anakinra in Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome )
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Anakinra in Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anakinra in Mucopolysaccharidosis III (MPS III)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Ruxolitinib Phosphate in Hand Dermatitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ruxolitinib Phosphate in Hand Dermatitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ruxolitinib Phosphate in Hand Dermatitis Drug Details: Ruxolitinib (INCB18424, Jakafi, Jakavi)...